Noninvasive treatment for erectile dysfunction in the neurogenically disabled population

Area of Science:

• Neuroscience
• Urology
• Rehabilitation Medicine

Background:

• Erectile dysfunction (ED) is a common sexual dysfunction in men with neurogenic disorders.
• Restoration of sexual function is a key priority in rehabilitation for these patients.

Purpose of the Study:

• To evaluate vacuum tumescence constriction therapy (VTCT) as a noninvasive treatment for ED in neurogenically disabled men.
• To assess patient adherence, impact on sexual activity, and partner satisfaction with VTCT.

Main Methods:

• A pilot study involving 30 male patients with neurogenic disorders (e.g., spinal cord injury, stroke, multiple sclerosis, diabetes mellitus).
• Patients were offered VTCT, and data were collected on device purchase, long-term usage, sexual activity frequency, and partner satisfaction.
• Morbidity associated with the therapy was also monitored.

Main Results:

• 17 out of 30 patients purchased the VTCT device.
• Over 50% of purchasers reported long-term device usage.
• The frequency of intercourse increased significantly, from 0.3 to 1.5 times per week.
• No substantial morbidity was reported.

Conclusions:

• Vacuum tumescence constriction therapy demonstrates potential as an effective and safe noninvasive treatment for erectile dysfunction in men with moderate to severe neurogenic disabilities.
• The therapy was successfully integrated into patients' sexual lives, with positive outcomes in sexual activity frequency and partner satisfaction.